NASDAQ:XRAY - DENTSPLY SIRONA Stock Price, Price Target & More

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

DENTSPLY SIRONA announced a quarterly dividend on Tuesday, June 26th. Shareholders of record on Friday, September 28th will be given a dividend of $0.0875 per share on Friday, October 12th. This represents a $0.35 annualized dividend and a yield of 0.78%. The ex-dividend date is Thursday, September 27th. View DENTSPLY SIRONA's Dividend History.

DENTSPLY SIRONA Inc (NASDAQ:XRAY) released its quarterly earnings results on Sunday, May, 6th. The medical instruments supplier reported $0.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.03. The medical instruments supplier earned $956.10 million during the quarter, compared to analysts' expectations of $942.20 million. DENTSPLY SIRONA had a positive return on equity of 8.63% and a negative net margin of 38.32%. DENTSPLY SIRONA's revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.49 EPS. View DENTSPLY SIRONA's Earnings History.

DENTSPLY SIRONA is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for DENTSPLY SIRONA.

DENTSPLY SIRONA updated its FY18 earnings guidance on Monday, May, 7th. The company provided EPS guidance of $2.55-2.65 for the period, compared to the Thomson Reuters consensus estimate of $2.70.

14 analysts have issued 12-month price targets for DENTSPLY SIRONA's stock. Their predictions range from $52.00 to $75.00. On average, they expect DENTSPLY SIRONA's stock price to reach $61.4167 in the next twelve months. This suggests a possible upside of 36.4% from the stock's current price. View Analyst Ratings for DENTSPLY SIRONA.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 5 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to DENTSPLY SIRONA include Straumann (SAUHF), Sartorius (SARTF), Nobel Biocare (NBHGF), Biomerica (BMRA), BIOLASE (BIOL) and Remedent (REMI).

Media stories about XRAY stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. DENTSPLY SIRONA earned a media sentiment score of 0.04 on Accern's scale. They also gave news headlines about the medical instruments supplier an impact score of 45.72 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

DENTSPLY SIRONA's stock is owned by many different of institutional and retail investors. Top institutional shareholders include GENERATION INVESTMENT MANAGEMENT LLP (5.20%), Bank of Montreal Can (0.10%), Channing Capital Management LLC (0.10%), Stonebridge Capital Management Inc. (0.06%), First National Bank of Omaha (0.05%) and Retirement Systems of Alabama (0.05%). Company insiders that own DENTSPLY SIRONA stock include Arthur D Kowaloff, Bret W Wise, Christopher T Clark, Donald M Jr Casey, Eric Brandt, Francis J Lunger, James G Mosch, Mark Thierer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman, Nicholas W Alexos, Rainer Berthan and Ulrich Michel. View Institutional Ownership Trends for DENTSPLY SIRONA.

XRAY stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Clinton Group Inc., Channing Capital Management LLC, Hartford Investment Management Co., Nisa Investment Advisors LLC, Hills Bank & Trust Co., Fjarde AP Fonden Fourth Swedish National Pension Fund and Bath Savings Trust Co. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Francis J Lunger, Michael C Alfano and Michael J Coleman. View Insider Buying and Selling for DENTSPLY SIRONA.

XRAY stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Stonebridge Capital Management Inc., FormulaFolio Investments LLC, Bank of Montreal Can, Cornerstone Wealth Management LLC, Rowland & Co. Investment Counsel ADV, IFM Investors Pty Ltd and DnB Asset Management AS. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Donald M Jr Casey, Mark Thierer and Nicholas W Alexos. View Insider Buying and Selling for DENTSPLY SIRONA.

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of XRAY stock can currently be purchased for approximately $45.03.

DENTSPLY SIRONA has a market capitalization of $10.24 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,550,000,000.00 in net income (profit) each year or $2.66 on an earnings per share basis. DENTSPLY SIRONA employs 16,100 workers across the globe.

DENTSPLY SIRONA's mailing address is 221 WEST PHILADELPHIA STREET, YORK PA, 17401. The medical instruments supplier can be reached via phone at 717-845-7511 or via email at [email protected]